1. Home
  2. ONCY vs BKKT Comparison

ONCY vs BKKT Comparison

Compare ONCY & BKKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ONCY
  • BKKT
  • Stock Information
  • Founded
  • ONCY 1998
  • BKKT 2018
  • Country
  • ONCY Canada
  • BKKT United States
  • Employees
  • ONCY N/A
  • BKKT N/A
  • Industry
  • ONCY Pharmaceuticals and Biotechnology
  • BKKT Computer Software: Prepackaged Software
  • Sector
  • ONCY Health Care
  • BKKT Technology
  • Exchange
  • ONCY Nasdaq
  • BKKT Nasdaq
  • Market Cap
  • ONCY 53.6M
  • BKKT 59.5M
  • IPO Year
  • ONCY 1999
  • BKKT N/A
  • Fundamental
  • Price
  • ONCY $0.54
  • BKKT $9.04
  • Analyst Decision
  • ONCY Strong Buy
  • BKKT Hold
  • Analyst Count
  • ONCY 4
  • BKKT 2
  • Target Price
  • ONCY $4.00
  • BKKT $13.13
  • AVG Volume (30 Days)
  • ONCY 215.9K
  • BKKT 688.9K
  • Earning Date
  • ONCY 03-07-2025
  • BKKT 03-19-2025
  • Dividend Yield
  • ONCY N/A
  • BKKT N/A
  • EPS Growth
  • ONCY N/A
  • BKKT N/A
  • EPS
  • ONCY N/A
  • BKKT N/A
  • Revenue
  • ONCY N/A
  • BKKT $3,490,220,000.00
  • Revenue This Year
  • ONCY N/A
  • BKKT N/A
  • Revenue Next Year
  • ONCY N/A
  • BKKT N/A
  • P/E Ratio
  • ONCY N/A
  • BKKT N/A
  • Revenue Growth
  • ONCY N/A
  • BKKT 347.39
  • 52 Week Low
  • ONCY $0.53
  • BKKT $5.57
  • 52 Week High
  • ONCY $1.53
  • BKKT $37.21
  • Technical
  • Relative Strength Index (RSI)
  • ONCY 26.43
  • BKKT 38.44
  • Support Level
  • ONCY $0.58
  • BKKT $8.51
  • Resistance Level
  • ONCY $0.65
  • BKKT $14.08
  • Average True Range (ATR)
  • ONCY 0.03
  • BKKT 1.42
  • MACD
  • ONCY -0.00
  • BKKT -0.03
  • Stochastic Oscillator
  • ONCY 1.36
  • BKKT 17.64

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.

About BKKT Bakkt Holdings Inc.

Bakkt Holdings Inc operates technology that connects the digital economy by offering a platform for crypto and redeeming loyalty points. Its institutional-grade technology platform provides a custody solution that caters to more experienced market participants to store crypto and provides consumers, businesses, and institutions with the ability to buy, sell, and store crypto in a simple, intuitive digital experience accessed via application programming interfaces (APIs) or embedded web experience and Loyalty offers a full spectrum of content that clients can make available to its customers when redeeming loyalty currencies. It generates revenue in the form of Subscription and service and Transaction revenue.

Share on Social Networks: